Lower, more frequent cisplatin dosing minimizes hearing loss in head and neck cancer. uri icon

authors

  • Fernandez, Katharine A
  • Ortiz, Candice Evita
  • Santa Maria, Peter L
  • Kullar, Peter
  • Khan, Saad A
  • Newlands, Shawn D
  • Nicole C. Schmitt, MD
  • Cunningham, Lisa L
  • Chowdhury, Abu S
  • Bonczkowski, Amanda
  • Allen, Paul D
  • Campbell, Maura H
  • Lee, David S
  • Malhotra, Charvi
  • Page, Brandi R
  • Mulford, Deborah A

publication date

  • October 22, 2025